🕵️ Beone Medicines Ltd. ($BEIGF)
SEC insider & ownership activity, last 12 months · CIK 1651308 · every row links its SEC filing
Over the last 12 months insiders sold $370.3M with no open-market buying against it. John Oyler sold $336.9M through a 10b5-1 trading plan in 126 lots (Sep–Aug). 1 planned sale is pending, the largest $45.4M (John V. Oyler). No red-flag 8-Ks in the window.
🚨 7 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 12 sellers, $370.3M (197 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| John Oyler | 0 | – | 126 | $336.9M | Aug 12, 2026 |
| Wang Xiaodong | 0 | – | 8 | $13.4M | Sep 8, 2026 |
| Xiaobin Wu | 0 | – | 19 | $8.8M | Aug 25, 2026 |
| Chan Lee | 0 | – | 22 | $8.0M | Aug 11, 2026 |
| Lai Wang | 0 | – | 5 | $1.2M | Jun 23, 2026 |
| Sanders Corazon (CORSEE) D. | 0 | – | 3 | $961K | May 22, 2026 |
| Aaron Rosenberg | 0 | – | 2 | $524K | Aug 3, 2026 |
| Baker BROS. Advisors LP | 0 | – | 4 | $262K | May 22, 2026 |
| Titus Benjamin Ball | 0 | – | 5 | $127K | Sep 1, 2026 |
| Dugan Margaret | 0 | – | 1 | $66K | May 22, 2026 |
| Riva Alessandro | 0 | – | 1 | $66K | May 22, 2026 |
| Yi Qingqing | 0 | – | 1 | $66K | Jun 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Baker BROS. Advisors LP | 7.8% | 13D | Sep 14, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 7.8% | 13D | Sep 14, 2026 | filing ↗ | |
| Julian C. Baker | 7.8% | 13D | Sep 14, 2026 | filing ↗ | |
| Felix J. Baker | 7.8% | 13D | Sep 14, 2026 | filing ↗ | |
| FBB3 LLC | exited | 13D | Sep 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Xiaodong Wang | $47.1M | Sep 8, 2026 | filing ↗ |
| Titus Benjamin Ball | $47K | Sep 1, 2026 | filing ↗ |
| Xiaobin Wu | $5.6M | Aug 25, 2026 | filing ↗ |
| Corazon D. Sanders | $788K | Aug 25, 2026 | filing ↗ |
| Chan Lee | $719K | Aug 11, 2026 | filing ↗ |
| John V. Oyler | $83.9M | Aug 10, 2026 | filing ↗ |
| Aaron Rosenberg | $362K | Aug 3, 2026 | filing ↗ |
| Chan Lee | $338K | Jul 30, 2026 | filing ↗ |
| Chan Lee | $638K | Jul 22, 2026 | filing ↗ |
| John V. Oyler | $156.1M | Jul 14, 2026 | filing ↗ |
| John V. Oyler | $45.4M | Jul 10, 2026 | filing ↗ |
| Pan-Oyler Foundation | $15.0M | Jul 10, 2026 | filing ↗ |
| Lai Wang | $296K | Jun 23, 2026 | filing ↗ |
| Xiaobin Wu | $357K | Jun 23, 2026 | filing ↗ |
| John Oyler | $934K | Jun 23, 2026 | filing ↗ |
| Chan Lee | $157K | Jun 16, 2026 | filing ↗ |
| Lai Wang | $310K | Jun 16, 2026 | filing ↗ |
| Xiaobin Wu | $362K | Jun 16, 2026 | filing ↗ |
| John Oyler | $981K | Jun 16, 2026 | filing ↗ |
| Corazon D. Sanders | $251K | Jun 15, 2026 | filing ↗ |
| Xiaobin Wu | $164K | Jun 11, 2026 | filing ↗ |
| Lai Wang | $198K | Jun 11, 2026 | filing ↗ |
| Aaron Rosenberg | $163K | Jun 11, 2026 | filing ↗ |
| Titus Benjamin Ball | $43K | Jun 11, 2026 | filing ↗ |
| Chan Lee | $110K | Jun 11, 2026 | filing ↗ |
| John Oyler | $501K | Jun 11, 2026 | filing ↗ |
| Titus Benjamin Ball | $37K | Jun 8, 2026 | filing ↗ |
| Chan Lee | $236K | Jun 8, 2026 | filing ↗ |
| Lai Wang | $368K | Jun 8, 2026 | filing ↗ |
| Xiaobin Wu | $400K | Jun 8, 2026 | filing ↗ |
| John Oyler | $1.3M | Jun 8, 2026 | filing ↗ |
| Qingqing Yi | $66K | Jun 1, 2026 | filing ↗ |
| Michael Goller | $65K | May 22, 2026 | filing ↗ |
| Ranjeev Krishana | $66K | May 22, 2026 | filing ↗ |
| Alessandro Riva | $66K | May 22, 2026 | filing ↗ |
| Margaret Dugan | $66K | May 22, 2026 | filing ↗ |
| Corazon D. Sanders | $66K | May 22, 2026 | filing ↗ |
| Chan Lee | $418K | May 13, 2026 | filing ↗ |
| Chan Lee | $1.6M | Feb 4, 2026 | filing ↗ |
| John V. Oyler | $31.9M | Dec 15, 2025 | filing ↗ |
| Corazon D. Sanders | $896K | Nov 26, 2025 | filing ↗ |
| Xiaobin Wu | $1.5M | Nov 17, 2025 | filing ↗ |
| Xiaobin Wu | $2.3M | Nov 13, 2025 | filing ↗ |
| Xiaobin Wu | $3.6M | Nov 12, 2025 | filing ↗ |
| Chan Lee | $4.7M | Oct 8, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 26, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Other events (8.01) | Jun 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 11, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Apr 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 14, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 17, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 16, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 13, 2025 | filing ↗ |
| New financial obligation (2.03) | Nov 13, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |